Dechert Advises Benta Pharma in its Takeover of Famar Lyon
Dechert LLP advised Benta Pharma in connection with its plans for takeover of Famar Lyon, authorized by the ruling from the Paris Commercial Court on July 20, 2020.
Benta Pharma, a Lebanese family-owned pharmaceutical group, aims to redeploy Benta Pharma/Famar in France and in Europe. Likewise, the COVID-19 range developed by Famar will be maintained. Investments in this manufacturing site are in keeping with government statements on restoring sovereignty in terms of pharmaceutical production.
Dechert’s multi-disciplinary team led by Paris office managing partner Alain Decombe, advised Benta Pharma on the following aspects:
- corporate/M&A: Isabelle Marguet, assisted by Sophie Lafay, counsel and Pierre-Henri Brieau, associate
- labor: Thibault Meiers assisted by Viviane Valilou, associate
- pharmaceutical regulatory aspects and foreign investment in France: Sophie Pelé
- antitrust: Laurence Bary.
About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for all clients.